Recent Finacing
Recent Raise
Prosensa is a Dutch biopharmaceutical company developing antisense oligonucleotide exon-skipping therapeutics to restore dystrophin for Duchenne muscular dystrophy, with additional RNA-modulating programs for DM1 and Huntington’s.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors